Lipid Disorders
From the Journals
Poor response to statins hikes risk of cardiovascular events
Patients with better outcomes were more likely to have initiated therapy with a more potent drug.
Conference Coverage
REDUCE-IT results suggest rethinking what’s elevated triglyceride
NEW ORLEANS –
From the Journals
Atorvastatin appears to lower cardiovascular risk in RA patients
Rheumatoid arthritis patients saw a reduced risk of cardiovascular events after adding statins to their treatment.
From the Journals
Canagliflozin lowers kidney failure risk in T2D: CREDENCE
The SGLT2 inhibitor also cut cardiovascular events.
News
Low LDL cholesterol may increase women’s risk of hemorrhagic stroke
Investigators found no association between HDL cholesterol and risk of hemorrhagic stroke or between total cholesterol and risk of hemorrhagic...
From the Journals
New data further suggest that stress does a number on the CV system
Video
Intermittent, but prolonged, calorie restriction may improve metabolic markers
NEW ORLEANS – A clinical trial showed improved metabolic markers in patients who went on the diet, especially in those with higher risk.
Latest News
Oxytocin dampens the brain’s food-related reward circuitry
NEW ORLEANS – The decreased brain activation may underlie oxytocin’s promise as a weight-loss medication.
Conference Coverage
Dapagliflozin’s cardiovascular benefits bloom in T2D with prior MI
NEW ORLEANS – New clinically important insights from DECLARE-TIMI 58 trial.
Conference Coverage
Alirocumab reduces both type 1 and 2 MIs
NEW ORLEANS – The ODYSSEY Outcomes trial provides first-ever evidence that lowering LDL prevents type 2 MI.
Conference Coverage
Studies link TMAO to microbiome, reveal new heart disease target
MIAMI – TMAO alters cholesterol and bile acid metabolism, upregulates inflammatory pathways, and promotes foam cell formation, all of which worsen...